AstraZeneca's Saphnelo gets nod in EU for systemic lupus erythematosus
(Alliance News) - AstraZeneca PLC on Friday said Saphnelo subcutaneous self-administration has been recommended for approval in the European Union for systemic lupus erythematosus. Read More